Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial

Joshua D. Lee; Edward V. Nunes; Patricia Novo; Jeanine May; Abigail Matthews; Paul Van Veldhuisen; Robert Lindblad; David Liu; John Rotrosen

doi:10.1097/ADM.0000000000000930

Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial

Joshua D. Lee, Edward V. Nunes, Patricia Novo, Jeanine May, Abigail Matthews, Paul Van Veldhuisen, Robert Lindblad, David Liu, John Rotrosen

Urban Initiative

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	382-385
Number of pages	4
Journal	Journal of Addiction Medicine
Volume	16
Issue number	4
DOIs	https://doi.org/10.1097/ADM.0000000000000930
State	Published - Jul 1 2022

ASJC Scopus subject areas

Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1097/ADM.0000000000000930

Cite this

@article{9afd1dd520ad4eef8100a7aa33a73f82,

title = "Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial",

author = "Lee, {Joshua D.} and Nunes, {Edward V.} and Patricia Novo and Jeanine May and Abigail Matthews and {Van Veldhuisen}, Paul and Robert Lindblad and David Liu and John Rotrosen",

note = "Funding Information: X:BOT was funded by NIDA (U10 DA013046, U10 DA013035). Suboxone was donated by Indivior (formerly Reckitt Benckiser). Vivitrol was purchased. ",

year = "2022",

month = jul,

day = "1",

doi = "10.1097/ADM.0000000000000930",

language = "English (US)",

volume = "16",

pages = "382--385",

journal = "Journal of Addiction Medicine",

issn = "1932-0620",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "4",

}

TY - JOUR

T1 - Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial

AU - Lee, Joshua D.

AU - Nunes, Edward V.

AU - Novo, Patricia

AU - May, Jeanine

AU - Matthews, Abigail

AU - Van Veldhuisen, Paul

AU - Lindblad, Robert

AU - Liu, David

AU - Rotrosen, John

N1 - Funding Information: X:BOT was funded by NIDA (U10 DA013046, U10 DA013035). Suboxone was donated by Indivior (formerly Reckitt Benckiser). Vivitrol was purchased.

PY - 2022/7/1

Y1 - 2022/7/1

UR - http://www.scopus.com/inward/record.url?scp=85136152250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85136152250&partnerID=8YFLogxK

U2 - 10.1097/ADM.0000000000000930

DO - 10.1097/ADM.0000000000000930

M3 - Comment/debate

C2 - 35960212

AN - SCOPUS:85136152250

SN - 1932-0620

VL - 16

SP - 382

EP - 385

JO - Journal of Addiction Medicine

JF - Journal of Addiction Medicine

IS - 4

ER -

Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this